Labocanna

Labocanna EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Labocanna (LCN.WA) as of Oct 18, 2026 is -173,273.71 PLN. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -93,992.85 PLN — a change of 84.35% (lower).

EBITDA

-173,273.71PLN

YoY

84.35%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Labocanna is 2025 -173,273.71 PLN. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Labocanna was 2024 -93,992.85 PLN. It decreases by 84.35% lower compared to the previous year.

The Labocanna EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-1.04 M PLN
Jan 1, 2019
-340,000.00 PLN
Jan 1, 2020
170,000.00 PLN
Jan 1, 2021
-190,000.00 PLN
Jan 1, 2022
-128,799.30 PLN
Jan 1, 2023
-412,910.20 PLN
Jan 1, 2024
-93,992.85 PLN
Jan 1, 2025
-173,273.71 PLN
The Labocanna EBITDA history
YEAREBITDAYoY
-173,273.71PLN+84.35%
-93,992.85PLN-77.24%
-412,910.20PLN+220.58%
-128,799.30PLN-32.21%
-190,000.00PLN-211.76%
170,000.00PLN-150.00%
-340,000.00PLN-67.31%
-1.04 MPLN+103.92%
-510,000.00PLN-1.92%
-520,000.00PLN-180.00%
650,000.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Labocanna is -173,273.71 PLN in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Labocanna changed from -93,992.85 PLN to -173,273.71 PLN, representing a 84.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Labocanna since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Labocanna historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Labocanna

All Key Metrics — Labocanna